GlobeNewswire Inc.··Rosen Law FirmNektar Therapeutics Faces Securities Class Action Over Alleged Misleading Trial Statements
Rosen Law Firm sues Nektar Therapeutics for alleged false statements about clinical trial protocols, seeking damages for injured investors as litigation moves forward.
EOSESLNONKTRsecurities class actionlead plaintiff